China Sets a Number for Humanoids: 10,000 on the Job
Beijing wants 10,000 humanoid robots in real commercial use by year-end. Robotera is already shipping by the thousand into China Post and SF Express — and the price war has begun.
The American humanoid race is being run in robots-per-hour and marquee customers. China is running a different race, and it just put a number on the finish line: more than 10,000 humanoid robots in commercial use by the end of 2026. Not in demos. Not in pilots. In jobs.
That target, set as a national initiative to accelerate humanoid robots and embodied AI, is a different kind of statement than a startup's production forecast. When a state apparatus picks a deployment number and pushes companies toward it, the question stops being whether the technology is impressive and becomes how fast it can be made boring — boring meaning reliable, cheap, and quietly doing work alongside people in factories, logistics centers, hospitals, and emergency operations. Beijing is explicitly redirecting the field away from showcases and toward workplaces.
Robotera is the proof of concept for the policy
The clearest evidence the target isn't fantasy comes from Robotera, the Beijing-based humanoid maker that began thousand-unit deliveries in the second quarter of 2026 and reported quarterly growth exceeding 300%. Those robots aren't going to research labs. Robotera has deployed humanoids across more than ten logistics centers operated by China Post and SF Express — two of the largest delivery networks on the planet — where the company says the machines are hitting up to 85% of human work efficiency.
That 85% figure is the one to sit with. A humanoid that does most of a human's job at a fraction of the recurring cost, across ten real distribution hubs, is no longer a science project; it's a line on an operations budget. And Robotera is funded to push: it raised more than $200 million in a round led by SF Group — the parent of the same SF Express now running its robots — following an earlier $143 million strategic financing that drew in HSG, IDG Capital, Hillhouse, and CICC Capital. When your logistics customer is also your lead investor, the deployment flywheel and the funding flywheel become the same wheel.
The capacity to actually hit the number
A 10,000-unit commercial target is meaningless without the factories to feed it, and that's where China's industrial-policy muscle shows. A high-capacity humanoid production line in Guangdong came online earlier in 2026, reported to be the country's first capable of building up to 10,000 humanoid robots a year — a single line sized to the national goal. Robotera, for its part, plans to expand beyond logistics into automotive manufacturing, electronics, and services.
This is the structural difference between the two leading humanoid ecosystems. The U.S. frontier is led by a few well-capitalized players — Figure tooling for thousands of units a year, Boston Dynamics committing its entire Atlas run to two partners — pursuing depth and capability. China is mobilizing a fleet: many manufacturers, state-backed deployment targets, and supply chains optimized to flood real workplaces fast. The American bet is that the best robot wins. The Chinese bet is that the most robots win.
The price war nobody can avoid
The flip side of mass commercialization is the part that's already making the industry nervous: when everyone races to ship the most units into the same factory floors, margins get crushed. Reporting from inside China's humanoid boom has begun warning of bruising price wars — the same dynamic that played out in Chinese EVs and solar, where furious domestic competition drove costs down so aggressively that it reshaped global markets and squeezed even the winners.
For buyers, that's the dream: humanoids commoditizing toward the price of industrial equipment rather than luxury research hardware. For makers, it's a gauntlet. A price war rewards whoever has the cheapest bill of materials, the highest yield, and the deepest balance sheet to absorb thin margins on the way to scale — and it tends to leave a graveyard of undercapitalized entrants behind. The same forces that make China's 10,000-unit target achievable are the forces that will make it brutal to compete in.
Why the West should read this carefully
It's tempting to wave off a national deployment target as state cheerleading, but the deployment data underneath it is real, and analysts have noticed. Morgan Stanley sharply raised its China humanoid shipment forecast as the industry entered what it framed as an early-commercialization catalyst phase — the moment when a technology stops being a curiosity and starts compounding on real revenue.
The strategic stakes are straightforward. Humanoids are general-purpose physical labor; whoever scales them first builds the manufacturing experience, the cost curve, and the deployment know-how that compounds for years. A country that gets 10,000 robots into real jobs in 2026 isn't just hitting a press-release number — it's running the largest live training program in industrial robotics, learning at fleet scale what a humanoid is actually good for and how cheaply it can be built. The pilot phase is ending. The part where the robots quietly go to work, by the thousand, has started — and right now it has a Beijing address.